Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin in schizophrenia
NCT02442817Phase 4Completed
- Sponsor
- University of Nevada, Reno
- Start
- Mar 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of linagliptin in schizophrenia, sponsored by University of Nevada, Reno. Started Mar 2015; status: completed.
02
Drugs
linagliptin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02442817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442817.